ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
Done
Inviting an author to review:
Polycatechol Mediated Small Interfering RNA Delivery for the Treatment of Ulcerative Colitis
Find an author and click ‘
Invite to review selected article
’ near their name.
Search for authors
Search for similar articles
Invite by email
1
views
1
references
Top references
cited by
82
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,496
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Multiple myeloma: Every year a new standard?
Author(s):
S. Vincent Rajkumar
1
Publication date
Created:
June 12 2019
Publication date
(Electronic):
June 12 2019
Journal:
Hematological Oncology
Publisher:
Wiley
Read this article at
ScienceOpen
Publisher
PMC
Further versions
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
50 years of ROAPE
Most cited references
1
Record
: found
Abstract
: not found
Article
: not found
Lenalidomide (LEN) maintenance (MNTC) after high-dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta-analysis (MA) of overall survival (OS).
Michel Attal
,
Antonio Palumbo
,
Sarah Holstein
…
(2016)
0
comments
Cited
7
times
– based on
0
reviews
Review now
Bookmark
All references
Author and article information
Journal
Title:
Hematological Oncology
Abbreviated Title:
Hematological Oncology
Publisher:
Wiley
ISSN (Print):
0278-0232
ISSN (Electronic):
1099-1069
Publication date Created:
June 12 2019
Publication date Created:
June 2019
Publication date (Electronic):
June 12 2019
Publication date (Print):
June 2019
Volume
: 37
Issue
: S1
Pages
: 62-65
Affiliations
[
1
]
Division of HematologyMayo Clinic Rochester MN
Article
DOI:
10.1002/hon.2586
PMC ID:
6570407
PubMed ID:
31187526
SO-VID:
a166acd7-9bb5-4ffb-9752-687ff8db1072
Copyright ©
© 2019
License:
http://doi.wiley.com/10.1002/tdm_license_1.1
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,496
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial
Authors:
Peter M Voorhees
,
Douglas W Sborov
,
Jacob Laubach
…
A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma
Authors:
Nikhil Munshi
,
Hervé Avet-Loiseau
,
Kenneth Anderson
…
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma
Authors:
Martin F. Kaiser
,
Andrew Hall
,
Katrina Walker
…
See all similar
Cited by
82
Multiple Myeloma: Available Therapies and Causes of Drug Resistance
Authors:
Vanessa D. Pinto
,
Rui Bergantim
,
Hugo Caires
…
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
Authors:
Fabio Morandi
,
Mahboubeh Yazdanifar
,
Claudia Cocco
…
Emerging agents and regimens for multiple myeloma
Authors:
Yang Yang
,
Yi Li
,
Huiyao Gu
…
See all cited by
Most referenced authors
217
J Chen
S. Kumar
R. Singh
See all reference authors
Version 1
- Current
Version 1